Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Banerji

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Hypertension (Dallas, Tex. : 1979)|December 11, 2025
Clinical Phenotypes in Hypertension: A Data-Driven Approach to Risk StratificationElisa Rauseo, Ahmed M Salih, Jackie Cooper, et al.
The EMBO Journal|February 17, 2001
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasisS J Mandriota, L Jussila, M Jeltsch, et al.
Redox Biology|March 6, 2022
Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic targetPhilipp Heher, Massimo Ganassi, Adelheid Weidinger, et al.
The Journal of Urology|March 16, 2016
Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate CancerKhanh N Pham, Jennifer Cullen, Lauren M Hurwitz, et al.
Current Oncology (Toronto, Ont.)|March 12, 2019
Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancerS A Laurie, S Banerji, N Blais, et al.
Current Oncology (Toronto, Ont.)|June 23, 2016
Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancerB Melosky, J Agulnik, R Albadine, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of <i>ROS1-</i>positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.
NPJ Breast Cancer|February 9, 2026
Normal breast tissue (NBT)-classifiers: advancing compartment classification in normal breast histologySiyuan Chen, Mario Parreno-Centeno, Graham Booker, et al.
Oncotarget|August 18, 2015
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancerMeng-Lay Lin, Hetal Patel, Judit Remenyi, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Hypertension (Dallas, Tex. : 1979)|December 11, 2025
Clinical Phenotypes in Hypertension: A Data-Driven Approach to Risk StratificationElisa Rauseo, Ahmed M Salih, Jackie Cooper, et al.
The EMBO Journal|February 17, 2001
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasisS J Mandriota, L Jussila, M Jeltsch, et al.
Redox Biology|March 6, 2022
Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic targetPhilipp Heher, Massimo Ganassi, Adelheid Weidinger, et al.
The Journal of Urology|March 16, 2016
Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate CancerKhanh N Pham, Jennifer Cullen, Lauren M Hurwitz, et al.
Current Oncology (Toronto, Ont.)|March 12, 2019
Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancerS A Laurie, S Banerji, N Blais, et al.
Current Oncology (Toronto, Ont.)|June 23, 2016
Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancerB Melosky, J Agulnik, R Albadine, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of <i>ROS1-</i>positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.
NPJ Breast Cancer|February 9, 2026
Normal breast tissue (NBT)-classifiers: advancing compartment classification in normal breast histologySiyuan Chen, Mario Parreno-Centeno, Graham Booker, et al.
Oncotarget|August 18, 2015
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancerMeng-Lay Lin, Hetal Patel, Judit Remenyi, et al.
Pageof 13